89Zr-DS-5573-a

N/A

Report date: 2026/05/09 20:00:18

NME

Base Information

Drug Name89Zr-DS-5573-a

Drug Alias Name89Zr-DS-5573a89Zr-DS-5573-a

ClassificationRadiation-emitting products > Nuclides > Zirconium > 89ZrRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[5]

Mechanisms of ActionCD276 antigen inhibitors

TargetsCD276 antigen

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDaiichi Sankyo Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A